Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Koi Peptides meets each of those criteria for BPC-157 sourcing, which is why it leads the Canadian research supplier list for 2026
Headaches GLP-1-related headaches occur in a subset of users, typically during the first few weeks or after dose escalation
Many feel improvement in energy and mood within days, while long-term benefits develop with consistent use
In a phase 2 clinical trial conducted on an obese population, over a 26-week period, patients who were administered a dose range of efinopegdutide from 5 mg to 10 mg experienced a weight reduction of up to 11.8%
US$ 21.86
US$ 20.40
US$ 26.08
